REGAIN

Retinal Gene Alteration in XLRP

 Coordinatore JUSTUS-LIEBIG-UNIVERSITAET GIESSEN 

Spiacenti, non ci sono informazioni su questo coordinatore. Contattare Fabio per maggiori infomrazioni, grazie.

 Nazionalità Coordinatore Germany [DE]
 Totale costo 1˙471˙840 €
 EC contributo 1˙471˙840 €
 Programma FP7-IDEAS-ERC
Specific programme: "Ideas" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)
 Code Call ERC-2012-StG_20111109
 Funding Scheme ERC-SG
 Anno di inizio 2013
 Periodo (anno-mese-giorno) 2013-01-01   -   2017-12-31

 Partecipanti

# participant  country  role  EC contrib. [€] 
1    JUSTUS-LIEBIG-UNIVERSITAET GIESSEN

 Organization address address: Ludwigstrasse 23
city: GIESSEN
postcode: 35390

contact info
Titolo: Dr.
Nome: Christian Maarten
Cognome: Veldman
Email: send email
Telefono: +49 641 9912117
Fax: +49 641 9912109

DE (GIESSEN) hostInstitution 1˙471˙840.00
2    JUSTUS-LIEBIG-UNIVERSITAET GIESSEN

 Organization address address: Ludwigstrasse 23
city: GIESSEN
postcode: 35390

contact info
Titolo: Dr.
Nome: Knut
Cognome: Stieger
Email: send email
Telefono: +49 641 98543835
Fax: +49 641 98543888

DE (GIESSEN) hostInstitution 1˙471˙840.00

Mappa


 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

photoreceptors    frequency    repair    hdr    length    treatment    strategy    co    template    vitro    expression    conversion    tract    xlrp    gene    dna    inducing    proteins    strand    vivo   

 Obiettivo del progetto (Objective)

'In this project the applicant proposes to develop a treatment strategy for a devastating blinding disorder affecting photoreceptor function within the first decade of life, X-linked Retinitis pigmentosa (XLRP). No treatment option exists to date. The proposed treatment strategy is based on the idea of inducing homology directed repair (HDR) of the mutation by promoting the exchange between the endogenous mutated chromosomal sequence and an exogenous repair DNA template at a double strand break (DSB) site in vivo. The treatment will be realized by co-delivery of endonucleases and the template DNA via adeno-associated virus (AAV) based gene transfer. However, This strategy has never been applied in the retina in vivo and therefore, several parameters are unknown, i.e. the average frequency of HDR in photoreceptors, whether DNA repair will take place through HDR or not, and the average length of the DNA conversion tract during HDR. The project includes the following parts: 1. Establishing the HDR frequency in photoreceptors in vivo: it is planned to optimize the frequency by co-delivery of trophic factors for the stimulation of the cellular repair machinery. 2. Inducing a bias of repair events towards HDR: it is planned to use nickases that only cut one DNA strand or will edit the expression profile of sensor proteins in the repair pathway in vitro and in vivo. 3. Optimization of the DNA conversion tract length: the expression profiles of helicases and other repair proteins are edited in vitro and in vivo. 4. Treatment of the PRGR2793delA mouse model: The optimized treatment settings are identified in order to test them for functional and morphological rescue effects. Results from this study will significantly advance the state of the art in targeted gene correction strategies in vivo and patients with XLRP and other hereditary disorders will potentially benefit from it through extrapolating the results for a broader application.'

Altri progetti dello stesso programma (FP7-IDEAS-ERC)

INNOSTOCH (2009)

INNOVATIONS IN STOCHASTIC ANALYSIS AND APPLICATIONS with emphasis on STOCHASTIC CONTROL AND INFORMATION

Read More  

FPTOPT (2011)

First-passage times and optimization of target search strategies

Read More  

PEPTIDELEARNING (2014)

The Role of Neuropeptides in Learning and Memory

Read More